6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance
- 1 September 2006
- journal article
- research article
- Published by Elsevier BV in Cancer Genetics and Cytogenetics
- Vol. 169 (2), 150-153
- https://doi.org/10.1016/j.cancergencyto.2006.04.009
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Neurological aspects of multiple myeloma and related disordersBest Practice & Research Clinical Haematology, 2005
- Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceBlood, 2003
- Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cellsSeminars in Oncology, 2003
- Genetics and cytogenetics of Waldenstrom's macroglobulinemiaSeminars in Oncology, 2003
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletionsBlood, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002
- Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomyLeukemia, 2001
- Waldenström's MacroglobulinemiaThe Oncologist, 2000
- The Spectrum of IgM Monoclonal Gammopathy in 430 CasesMayo Clinic Proceedings, 1987